Sentences with phrase «women with breast cancer whose»

Herceptin has proved to be effective in prolonging the lives of the 12 percent of women with breast cancer whose malignancy hasn't spread to other organs, and whose cancer is HER2 - positive.

It all boils down to the right ratios: in the landmark British study (Mohr, PE; Br J Cancer 1996) researchers found that women with breast cancer whose progesterone level at the time of surgery was above the adequate level, had significantly improved chances of survival.

Not exact matches

Women with the KRAS - variant are also more susceptible to triple - negative breast cancer, tumors whose growth is not fueled by the hormones estrogen and progesterone, or by the presence of a particular genetic mutation known as HER2, which promotes cancer cell growth.

«These are women with advanced metastatic cancer whose disease was kept in check without the use of toxic and life - disrupting chemotherapy,» says Dr. Massimo Cristofanilli, M.D., Director of the Breast Care Center at Thomas Jefferson University and senior author of the study.

Women whose mothers had elevated levels of DDT in their blood had a nearly fourfold increase in risk of developing breast cancer by age 52, compared with controls who were matched for a variety of factors, including maternal history of breast cancer.

The researchers, studying women with node - negative breast cancer — the small, early tumors sought by mammography — found that by adding E-cadherin to other biomarkers that they have studied they are able to distinguish those patients with a 90 percent long - term survival from those whose survival is only 44 percent.

After adjusting for common factors that influence breast cancer risk, Henderson and colleagues found that women whose mammograms were classified as false - positive who were referred for additional imaging had a 39 percent increased chance of developing subsequent breast cancer during the 10 - year follow - up period, compared with women with a true - negative result.

Women whose mammograms were classified as false - positive but were referred for a breast biopsy had a 76 percent increased chance of developing subsequent breast cancer compared with women with a true - negative reWomen whose mammograms were classified as false - positive but were referred for a breast biopsy had a 76 percent increased chance of developing subsequent breast cancer compared with women with a true - negative rewomen with a true - negative result.